Immatics (IMTX) Change in Acquisitions & Divestments (2022 - 2025)
Immatics (IMTX) reported Change in Acquisitions & Divestments of $34.7 million for Q4 2025, down 32.55% on a YoY basis from $51.4 million in Q4 2024, and down 76.04% sequentially from $144.7 million in Q3 2025.
Immatics (IMTX) Change in Acquisitions & Divestments (2022 - 2025) Analysis & Trends
Immatics (IMTX) has 4 years of Change in Acquisitions & Divestments data on file, last reported at $34.7 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Acquisitions & Divestments fell 32.55% year-over-year to $34.7 million; the trailing twelve-month figure through Dec 2025 stood at $603.3 million (up 77.29% YoY), and the FY2025 full-year result was $621.2 million, up 82.54% from the prior year.
- Change in Acquisitions & Divestments fell to $34.7 million in Q4 2025, from $144.7 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $324.5 million in Q1 2025 to a low of -$246.5 million in Q4 2023.
- A 4-year average of $68.6 million and a median of $71.9 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- Across the five-year window, Change in Acquisitions & Divestments soared 1628.65% in 2023 and tumbled 33.4% in 2025, its largest moves.
- Tracing IMTX's Change in Acquisitions & Divestments over 4 years: stood at $6.1 million in 2022, then slumped by 4152.08% to -$246.5 million in 2023, then soared by 120.84% to $51.4 million in 2024, then slumped by 32.55% to $34.7 million in 2025.
- Business Quant data shows IMTX's Change in Acquisitions & Divestments at $34.7 million in Q4 2025, $144.7 million in Q3 2025, and $99.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,583.17 Bn | 67,582.89 Bn | - |
| 2 | Nanobiotix | 1,947.22 Bn | 1,947.15 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 473.21 Bn | 468.42 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.29 Bn | 116.04 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - |
| 8 | Argenx Se | 56.63 Bn | 51.45 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.79 Bn | 37.79 Bn | - |
| 10 | Immatics | 1.13 Bn | 582.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.65 Mn |
| Dec 31, 2025 | 34.65 Mn |
| Sep 30, 2025 | 144.65 Mn |
| Sep 30, 2025 | 144.65 Mn |
| Jun 30, 2025 | 99.40 Mn |
| Jun 30, 2025 | 99.40 Mn |
| Mar 31, 2025 | 324.55 Mn |
| Mar 31, 2025 | 324.55 Mn |
| Dec 31, 2024 | 51.38 Mn |
| Dec 31, 2024 | 51.38 Mn |
| Sep 30, 2024 | 76.67 Mn |
| Sep 30, 2024 | 76.67 Mn |
| Jun 30, 2024 | 149.25 Mn |
| Jun 30, 2024 | 149.25 Mn |
| Mar 31, 2024 | 62.96 Mn |
| Mar 31, 2024 | 62.96 Mn |
| Dec 31, 2023 | -246.54 Mn |
| Dec 31, 2023 | -246.54 Mn |
| Sep 30, 2023 | 70.35 Mn |
| Sep 30, 2023 | 70.35 Mn |